Financial News
Editas Medicine (NQ: EDIT )
5.030
+0.030
(+0.60%)
Streaming Delayed Price
Updated: 11:29 AM EDT, Jul 22, 2024
Add to My Watchlist
All News about Editas Medicine
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://g.foolcdn.com/editorial/images/737122/patient-sitting-on-hospital-bed.jpg)
![](/next-assets/images/schema-image-default.png)
What 6 Analyst Ratings Have To Say About Editas Medicine
June 13, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
6 Analysts Have This to Say About Editas Medicine
May 08, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://g.foolcdn.com/editorial/images/737749/3-worried-investors-talk-at-a-table.jpg)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](/next-assets/images/schema-image-default.png)
Editas Medicine: Q1 Earnings Insights
May 05, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/736667/concerned-investor-with-two-people-in-background.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/15/john_wiley__sons_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/736168/parabola.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/15/gambling.com_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
Editas Medicine Announces Offering of Common Stock
June 14, 2023
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_12358.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/stocks-to-buy-greedy1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2023/06/09/edit.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2019/12/gene-editing.jpg)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/01/screenshot_2023-06-01_at_5.40.36_pm.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/07/short-squeeze-stocks.jpg)
![](https://g.foolcdn.com/editorial/images/733047/scientists-examine-cell-make-up-microscope-biotech.jpg)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/15/oneok_-_logo.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.